Company No:
Contents
DIRECTORS | Mrs Tania Aube |
Mrs Emma Jeanne Mcferran | |
Mrs Hannah Rose Thomson | |
Mr Cian Arjun Gregory Weeresinghe |
REGISTERED OFFICE | Keynsham House |
33 Bath Road | |
Keynsham | |
Bristol | |
BS31 1SL | |
United Kingdom |
COMPANY NUMBER | 12328518 (England and Wales) |
ACCOUNTANT | OnTheGo Accountants Limited |
330 Holborn Gate | |
High Holborn | |
London | |
WC1V 7QH |
The directors present their annual report and the unaudited financial statements of the Company for the financial year ended 31 December 2023.
PRINCIPAL ACTIVITIES
GOING CONCERN
DIRECTORS
The directors, who served during the financial year and to the date of this report except as noted, were as follows:
|
|
|
|
|
|
|
Approved by the Board of Directors and signed on its behalf by:
Mrs Hannah Rose Thomson
Director |
2023 | 2022 | |||
£ | £ | |||
Gross profit |
|
|
||
Administrative expenses | (
|
(
|
||
Operating loss and loss before taxation | (
|
(
|
||
Tax on loss |
|
|
||
Loss for the financial year | (
|
(
|
Note | 2023 | 2022 | ||
£ | £ | |||
Fixed assets | ||||
Tangible assets | 5 |
|
|
|
2,644 | 8,694 | |||
Current assets | ||||
Debtors |
|
|
||
Cash at bank and in hand |
|
|
||
190,385 | 972,073 | |||
Creditors: amounts falling due within one year | (
|
(
|
||
Net current assets | 173,757 | 950,360 | ||
Total assets less current liabilities | 176,401 | 959,054 | ||
Net assets |
|
|
||
Capital and reserves | ||||
Called-up share capital | 7 |
|
|
|
Share premium account |
|
|
||
Other reserves |
|
|
||
Profit and loss account | (
|
(
|
||
Total shareholders' funds |
|
|
Directors' responsibilities:
The financial statements of Juniper Jean Limited (registered number:
Mrs Hannah Rose Thomson
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.
Juniper Jean Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Keynsham House, 33 Bath Road, Keynsham, Bristol, BS31 1SL, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.
Exchange differences are recognised in the Profit and Loss Account in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.
Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.
Juniper Jean recognises equity-settled share-based payments in line with IFRS 2 "Share-based Payment". The company grants share options to its employees, with a vesting schedule of 20% after one year, a further 30% after two years, and the final 50% after three years.
The fair value of these share options is calculated at the grant date, based on the share value at Juniper Jean's latest investment round, reflecting market conditions and expectations.
Considering a 25% employee dropout rate, the expected vesting numbers were adjusted. Consequently, the total share-based payment expense for the year, accounting for this attrition, was £9,225.30. This expense is recorded under the nominal code 'Share-based Payments' in the profit or loss, distributed evenly over the vesting period.
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.
Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.
The company recognizes research and development costs in accordance with FRS 102. Research costs are expensed as incurred. Development expenditures are capitalized only when the expenditure can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the company intends to and has sufficient resources to complete development and to use or sell the asset.
Tangible assets |
|
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.
2023 | 2022 | ||
Number | Number | ||
Monthly average number of persons employed by the Company during the year, including directors |
|
|
2023 | 2022 | ||
£ | £ | ||
Current tax on loss | |||
UK corporation tax | (
|
(
|
|
Total current tax | (
|
(
|
|
Deferred tax | |||
Origination and reversal of timing differences | (
|
(
|
|
Total deferred tax | (
|
(
|
|
Total tax on loss | (
|
(
|
The March 2021 Budget announced a further increase to the main rate of corporation tax to 25% from April 2023 as well as introducing a small profits rate of 19%. These rates were substantively enacted via the Finance Bill 2021 on 24 May 2021.
At the Balance Sheet date, it was estimated that the Company’s future profits will be applicable to the small profits rate and therefore deferred tax balances as at 31 December 2023 continue to be measured at 19%.
2023 | 2022 | ||
£ | £ | ||
At the beginning of financial year | (
|
(
|
|
Credited to the Profit and Loss Account |
|
|
|
|
|
||
At the end of financial year | (
|
(
|
2023 | 2022 | ||
£ | £ | ||
Allotted, called-up and fully-paid | |||
|
|
|